AngioDynamics (ANGO) News Today → Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (From InvestorPlace) (Ad) Free ANGO Stock Alerts $6.04 -0.38 (-5.92%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 6, 2024 | finance.yahoo.comAngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsMay 6, 2024 | businesswire.comAngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsMay 3, 2024 | nasdaq.comAngioDynamics, Inc. Common Stock (ANGO)May 2, 2024 | finance.yahoo.comOppenheimer Predicts Over 100% Rally for These 2 Healthcare StocksApril 17, 2024 | finance.yahoo.comAngioDynamics, Inc. (ANGO) Interactive Stock Chart - Yahoo FinanceApril 15, 2024 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Sees Large Decline in Short InterestAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 2,250,000 shares, a drop of 8.5% from the March 15th total of 2,460,000 shares. Based on an average daily volume of 575,400 shares, the short-interest ratio is currently 3.9 days.April 10, 2024 | finance.yahoo.comInsider Spends US$67k Buying More Shares In AngioDynamicsApril 9, 2024 | seekingalpha.comA Leaner AngioDynamics Is A High-Risk Execution-Driven StoryApril 9, 2024 | insidertrades.comJames C. Clemmer Acquires 10,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) StockApril 8, 2024 | marketbeat.comInsider Buying: AngioDynamics, Inc. (NASDAQ:ANGO) CEO Purchases 10,000 Shares of StockAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) CEO James C. Clemmer acquired 10,000 shares of AngioDynamics stock in a transaction dated Monday, April 8th. The shares were acquired at an average price of $6.70 per share, with a total value of $67,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 539,066 shares of the company's stock, valued at $3,611,742.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.April 8, 2024 | finance.yahoo.comAngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call TranscriptApril 6, 2024 | finance.yahoo.comAngioDynamics Third Quarter 2024 Earnings: Misses ExpectationsApril 6, 2024 | seekingalpha.comAngioDynamics (ANGO) Q3 2024 Earnings Call TranscriptApril 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for AngioDynamics Amid Strong Sales and Strategic Growth OpportunitiesApril 6, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for AngioDynamics Amidst Strategic Growth and Med-Tech Sector PotentialApril 5, 2024 | msn.comAngioDynamics upgraded at Oppenheimer on pipeline progressApril 4, 2024 | finance.yahoo.comMedical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock SoarsApril 4, 2024 | marketwatch.comAngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 SystemApril 4, 2024 | markets.businessinsider.comANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024April 4, 2024 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Releases FY 2024 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.580--0.540 for the period, compared to the consensus estimate of -0.430. The company also issued revenue guidance of $270.0 millionillion-$275.0 millionillion, compared to the consensus estimate of $312.1 millionillion.April 4, 2024 | marketwatch.comAngioDynamics Gets FDA Clearance For Pulmonary Embolism TreatmentApril 4, 2024 | marketwatch.comAngioDynamics Cut Fiscal-Year Revenue Outlook, Reflecting DivestmentsApril 4, 2024 | sfgate.comAngioDynamics: Fiscal Q3 Earnings SnapshotApril 4, 2024 | markets.businessinsider.comAngioDynamics: FDA Clears AlphaVac F1885 System In Treatment Of Pulmonary EmbolismApril 4, 2024 | markets.businessinsider.comAngioDynamics Q3 Loss Sharply Widens; Slashes FY24 OutlookApril 4, 2024 | msn.comAngioDynamics gets FDA clearance for pulmonary embolism treatment deviceApril 4, 2024 | businesswire.comAngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset DivestitureApril 4, 2024 | businesswire.comAngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PEApril 2, 2024 | msn.comAngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement AgreementApril 2, 2024 | markets.businessinsider.comAngioDynamics Settles All Patent Litigation With C.R. BardApril 1, 2024 | marketwatch.comAngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & CoApril 1, 2024 | businesswire.comAngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.March 19, 2024 | businesswire.comAngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024March 18, 2024 | marketbeat.comQ3 2024 EPS Estimates for AngioDynamics, Inc. Reduced by Zacks Research (NASDAQ:ANGO)AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Zacks Research lowered their Q3 2024 earnings per share (EPS) estimates for AngioDynamics in a research report issued on Wednesday, March 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn ($0.15) per sMarch 18, 2024 | marketbeat.comShort Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 8.5%AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 29th, there was short interest totalling 2,300,000 shares, a growth of 8.5% from the February 14th total of 2,120,000 shares. Based on an average daily trading volume, of 522,400 shares, the days-to-cover ratio is presently 4.4 days.March 15, 2024 | marketbeat.comQ3 2026 EPS Estimates for AngioDynamics, Inc. Lowered by Zacks Research (NASDAQ:ANGO)AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Equities researchers at Zacks Research cut their Q3 2026 earnings estimates for AngioDynamics in a research note issued to investors on Wednesday, March 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will posMarch 14, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Grows Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Jacobs Levy Equity Management Inc. grew its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 62.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 713,899 shares of the medical instruments supplieMarch 6, 2024 | businesswire.comAngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services ConferenceMarch 5, 2024 | marketbeat.comTrexquant Investment LP Makes New Investment in AngioDynamics, Inc. (NASDAQ:ANGO)Trexquant Investment LP purchased a new stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 187,854 shares of the medical instruments supplier's stock, vMarch 4, 2024 | investorplace.comHidden Gems: 7 Oversold Stocks Ready for a Major ReboundMarch 1, 2024 | finance.yahoo.comAngioDynamics (ANGO) Gains But Lags Market: What You Should KnowFebruary 26, 2024 | marketbeat.comAcadian Asset Management LLC Invests $2.63 Million in AngioDynamics, Inc. (NASDAQ:ANGO)Acadian Asset Management LLC purchased a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 360,041 shares of the medical instrumFebruary 18, 2024 | investing.comAngioDynamics sells PICC and Midline portfolios for $45 millionFebruary 17, 2024 | finance.yahoo.comELV Feb 2024 410.000 putFebruary 16, 2024 | msn.comAngioDynamics divests PICC, Midline product portfolioFebruary 16, 2024 | finance.yahoo.comAngioDynamics (ANGO) Divests Its PICC & Midline BusinessesFebruary 16, 2024 | marketbeat.comPrincipal Financial Group Inc. Decreases Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Principal Financial Group Inc. trimmed its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 94.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,411 shares of the medical instruments supplier's stock after sellingFebruary 15, 2024 | marketwatch.comAngioDynamics Sells PICC, Midline Products for Up to $45 MillionFebruary 15, 2024 | finance.yahoo.comAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 MillionFebruary 15, 2024 | businesswire.comAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. ANGO Media Mentions By Week ANGO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼0.000.42▲Average Medical News Sentiment ANGO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼03▲ANGO Articles Average Week Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Accuray News Today Cytosorbents News Today Surmodics News Today Orthofix Medical News Today Utah Medical Products News Today AVITA Medical News Today TriSalus Life Sciences News Today Inovio Pharmaceuticals News Today Sight Sciences News Today Fractyl Health News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
